1-7 of 7
Stanley R. Riddell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial

Shihong Zhang, Karan Kohli, R. Graeme Black, Lu Yao, Sydney M. Spadinger, Qianchuan He, Venu G. Pillarisetty, Lee D. Cranmer, Brian A. Van Tine, Cassian Yee, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones, Seth M. Pollack
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2019) 7 (8): 1237–1243.
https://doi.org/10.1158/2326-6066.CIR-18-0940
Published: 01 August 2019
View article titled, Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Open the PDF for Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations

Joshua R. Veatch, Brenda L. Jesernig, Julia Kargl, Matthew Fitzgibbon, Sylvia M. Lee, Christina Baik, Renato Martins, A. McGarry Houghton, Stanley R. Riddell
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2019) 7 (6): 910–922.
https://doi.org/10.1158/2326-6066.CIR-18-0402
Published: 03 June 2019
View article titled, Endogenous CD4<sup>+</sup> T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic <em>KRAS</em> and <em>ERBB2</em> (<em>Her2</em>) Driver Mutations
Open the PDF for Endogenous CD4<sup>+</sup> T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic <em>KRAS</em> and <em>ERBB2</em> (<em>Her2</em>) Driver Mutations in another window
Includes: Supplementary data
Journal Articles

Abstract A75: Designed Ankyrin Repeat Proteins (DARPins) as recognition motifs in chimeric antigen receptors

Ashwini Balakrishnan, Alexander I. Salter, Andreas Plückthun, Stanley R. Riddell
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (3_Supplement): A75.
https://doi.org/10.1158/2326-6074.TUMIMM16-A75
Published: 28 February 2017
View article titled, Abstract A75: Designed Ankyrin Repeat Proteins (DARPins) as recognition motifs in chimeric antigen receptors
Journal Articles

Preserved Activity of CD20-Specific Chimeric Antigen Receptor–Expressing T Cells in the Presence of Rituximab

Gregory A. Rufener, Oliver W. Press, Philip Olsen, Sang Yun Lee, Michael C. Jensen, Ajay K. Gopal, Barbara Pender, Lihua E. Budde, Jeffrey K. Rossow, Damian J. Green, David G. Maloney, Stanley R. Riddell, Brian G. Till
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (6): 509–519.
https://doi.org/10.1158/2326-6066.CIR-15-0276
Published: 31 May 2016
View article titled, Preserved Activity of CD20-Specific Chimeric Antigen Receptor–Expressing T Cells in the Presence of Rituximab
Open the PDF for Preserved Activity of CD20-Specific Chimeric Antigen Receptor–Expressing T Cells in the Presence of Rituximab in another window
Includes: Supplementary data
Journal Articles

Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor–Modified T Cells

Carolina Berger, Daniel Sommermeyer, Michael Hudecek, Michael Berger, Ashwini Balakrishnan, Paulina J. Paszkiewicz, Paula L. Kosasih, Christoph Rader, Stanley R. Riddell
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (2): 206–216.
https://doi.org/10.1158/2326-6066.CIR-14-0163
Published: 05 February 2015
View article titled, Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor–Modified T Cells
Open the PDF for Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor–Modified T Cells in another window
Includes: Supplementary data
Journal Articles

The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity

Michael Hudecek, Daniel Sommermeyer, Paula L. Kosasih, Anne Silva-Benedict, Lingfeng Liu, Christoph Rader, Michael C. Jensen, Stanley R. Riddell
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (2): 125–135.
https://doi.org/10.1158/2326-6066.CIR-14-0127
Published: 05 February 2015
View article titled, The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <em>In Vivo</em> Antitumor Activity
Open the PDF for The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <em>In Vivo</em> Antitumor Activity in another window
Includes: Supplementary data
Journal Articles

Cytotoxic T-cell Cytokines Put Cancer Under Arrest

Stanley R. Riddell
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (1): 23–25.
https://doi.org/10.1158/2326-6066.CIR-14-0218
Published: 06 January 2015
View article titled, Cytotoxic T-cell Cytokines Put Cancer Under Arrest
Open the PDF for Cytotoxic T-cell Cytokines Put Cancer Under Arrest in another window